Background:
Arnica montana is a popular traditional remedy widely used in complementary medicine, also for its
wound healing properties. Despite its acknowledged action in clinical settings at
various doses, the molecular aspects relating to how A. montana promotes wound healing remain to be elucidated. To fill this gap, we evaluated the
whole plant extract, in a wide range of dilutions, in THP-1 human cells, differentiated
into mature macrophages and into an alternative IL-4-activated phenotype involved
in tissue remodelling and healing.
Methods:
Real-time quantitative Reverse Transcription Polymerase Chain Reaction (PCR) analysis
was used to study the changes in the expression of a customized panel of key genes,
mainly cytokines, receptors and transcription factors.
Results:
On macrophages differentiated towards the wound healing phenotype, A. montana affected the expression of several genes. In particular CXC chemokine ligand 1 (CXCL1),
coding for an chief chemokine, exhibited the most consistent increase of expression,
while also CXC chemokine ligand 2 (CXCL2), Interleukin8 (IL8) and bone morphogenetic
protein (BMP2) were slightly up-regulated, suggesting a positive influence of A. montana on neutrophil recruitment and on angiogenesis. MMP1, coding for a metalloproteinase
capable of cleaving extracellular matrix substrates, was down-regulated. Most results
showed non-linearity of the dose-effect relationship.
Conclusions
This exploratory study provides new insights into the cellular and molecular mechanisms
of action of A. montana as a promoter of healing, since some of the genes it modifies are key regulators
of tissue remodelling, inflammation and chemotaxis.
Keywords
Zincum metallicum
- Homeopathic pathogenetic trials - Case reports